| Owlstone Medical Ltd.. (1/15/25). "Press Release: Owlstone Medical Announces $27 Million USD First Close in Series E Financing Round". Cambridge. |
2025-01-15 |
| bioMérieux S.A.. (1/13/25). "Press Release: bioMérieux Strengthens Its Point of Care Presence with the Acquisition of the Immunoassay Start-up SpinChip". Marcy l’Étoile. |
2025-01-13 |
| GSK plc. (1/13/25). "Press Release: GSK Enters Agreement to Acquire IDRx, Inc.". London. |
2025-01-13 |
| Coave Therapeutics (Horama S.A.). (1/9/25). "Press Release: Coave Therapeutics Secures €32 Million ($33 Million) in Series A Financing to Advance its Next-Generation Genetic Medicines". Paris. |
2025-01-09 |
| Oribiotech Ltd.. (1/9/25). "Press Release: Ori Biotech Expands Team to Advance IRO Commercialization and Industry Partnerships". London. |
2025-01-09 |
| Astraveus SAS. (1/9/25). "Press Release: Astraveus Announces World First End-to-End Production of CAR-T Cells Using Microfluidic Technology". Paris. |
2025-01-09 |
| Argobio SAS. (1/7/25). "Press Release: Next-generation RNA Company Inverna Therapeutics Launched by Argobio and University of Southern Denmark". Odense. |
2025-01-07 |
| Oribiotech Ltd.. (1/7/25). "Press Release: Ori Biotech Announces First Customer Deliveries of IRO to Leading CDMOs and Commercial CGT Manufacturers". London. |
2025-01-07 |
| Orbis Medicines ApS. (1/6/25). "Press Release: Orbis Medicines Raises EUR 90 Million Series A Funding Round to Develop Pipeline of Oral Macrocycles". Copenhagen. |
2025-01-06 |
| Ottimo Pharma Ltd.. (12/19/24). "Press Release: Ottimo Pharma Raises over $140 Million in Series A Financing". London & Boston, MA. |
2024-12-19 |
| 2cureX AB. (12/16/24). "Press Release: 2cureX AB Announces the Appointment of Dan Honeywell as CEO, Ushering in a New Era of Commercial Expansion of Breakthrough Precision Oncology Products". |
2024-12-16 |
| Selvita S.A.. (12/10/24). "Press Release: Selvita Strengthens Management Structure in Sales and Drug Development Segment". Kraków. |
2024-12-10 |
| Oribiotech Ltd.. (12/10/24). "Press Release: Ori Biotech and Fresenius Kabi Collaborate to Advance Modular, Scalable Manufacturing of Cell and Gene Therapies". London & Bad Homburg. |
2024-12-10 |
| Aqemia SAS. (12/10/24). "Press Release: Aqemia Hits $100 Million Funding Milestone, Paving Way to Clinical Trials and Global Expansion Starting with London, UK". Paris & London. |
2024-12-10 |
| Relation Therapeutics Ltd.. (12/10/24). "Press Release: Relation Announces Two Strategic Collaborations with GSK to Advance Therapeutics for Fibrotic Diseases and Osteoarthritis". London. |
2024-12-10 |
| Citryll B.V.. (12/9/24). "Press Release: Citryll Raises EUR 85 Million Series B to Advance Novel NET-Targeting Therapy for Immune-Mediated Inflammatory Disorders". Oss. |
2024-12-09 |
| Newcells Biotech Ltd.. (12/5/24). "Press Release: Newcells Biotech Raises Additional Funding from Investors". Newcastle. |
2024-12-05 |
| Muna Therapeutics ApS. (12/5/24). "Press Release: Muna Therapeutics Announces Strategic Alliance with GSK to Accelerate Development of Novel Treatments for Alzheimer’s Disease". Copenhagen. |
2024-12-05 |
| Antag Therapeutics. (12/4/24). "Press Release: Antag Therapeutics Announces €80 Million Series A Financing". Copenhagen. |
2024-12-04 |
| Abselion (HexagonFab Ltd.). (12/4/24). "Press Release: Abselion Raises £6.6 Million Led by M Ventures to Bring Disruptive At-line Protein Analyser, Amperia, to Market". Cambridge. |
2024-12-04 |
| Orbit Discovery Ltd.. (12/3/24). "Press Release: Orbit Discovery and Evergreen Theragnostics Expand Research Collaboration to Advance Targeted Therapeutics Development". Oxford & Springfield, NJ. |
2024-12-03 |
| Nouscom S.r.l.. (12/3/24). "Press Release: Nouscom Appoints Seasoned Executive Eckhard Niemeier as Chief Business Officer". Basel. |
2024-12-03 |
| H. Lundbeck A/S. (11/18/24). "Press Release: Lundbeck Announces Expiration of Longboard Tender Offer and That All Tender Offer Conditions Are Fulfilled". |
2024-11-28 |
| Cradle Bio B.V.. (11/26/24). "Press Release: Cradle Raises $73m Series B Led by IVP to Accelerate Adoption of AI-powered Protein Engineering". Amsterdam & Zurich. |
2024-11-26 |
| Acadia Pharmaceuticals Inc.. (11/26/24). "Press Release: Acadia Pharmaceuticals Announces Exclusive License Agreement with Saniona for SAN711". San Diego, CA. |
2024-11-26 |
| Saniona AB. (11/26/24). "Press Release: Saniona Announces Licensing Agreement with Acadia Pharmaceuticals for SAN711 in Neurological Diseases". |
2024-11-26 |
| Metrion Biosciences Ltd.. (11/25/24). "Press Release: Metrion Biosciences Appoints Lee Patterson as CEO". Cambridge. |
2024-11-25 |
| Adcendo ApS. (11/25/24). "Press Release: Adcendo ApS Completes Oversubscribed $135 Million Series B Financing to Advance First-in-class ADC Pipeline". Copenhagen. |
2024-11-25 |
| Bico Group AB. (11/25/24). "Press Release: Cellink Announces Further Right-sizing and Launches Sharpened Commercial Agenda". |
2024-11-25 |
| Bico Group AB. (11/21/24). "Press Release: Bico Has Entered into an Agreement to Divest Nanoscribe". |
2024-11-21 |
| Tagomics Ltd.. (11/20/24). "Press Release: Tagomics Announces a Multiomic Profiling Co-Marketing Agreement with Agilent". Cambridge. |
2024-11-20 |
| Revvity, Inc.. (11/20/24). "Press Release: Revvity Broadens Relationship with Genomics England to Advance Genomics in the UK". Waltham, MA. |
2024-11-20 |
| Glox Therapeutics Ltd.. (11/20/24). "Press Release: Glox Therapeutics Awarded £1M PACE Grant to Accelerate Development of Precision Antibiotics Against Antimicrobial-resistant Pathogens". Glasgow. |
2024-11-20 |
| CRISPR Therapeutics AG. (11/14/24). "Press Release: CRISPR Therapeutics to Present at the Jefferies London Healthcare Conference". Zug & Boston, MA. |
2024-11-14 |
| Vilnius University. (11/11/24). "Press Release: Vilnius University Researchers Uncover New Gene Silencing Mechanism". |
2024-11-11 |
| Kynos Therapeutics Ltd.. (10/29/24). "Press Release: Dr. Falk Pharma Acquires Kynos Therapeutics, Adding Acute Pancreatitis as a Therapeutic Focus and Further Strengthening Its Development Portfolio". Freiburg. |
2024-10-29 |
| Ottimo Pharma Ltd.. (10/28/24). "Press Release: Ottimo Pharma Emerges from Stealth with Backing from Medicxi and Management Team Led by David Epstein to Accelerate Development of a Novel PD1/VEGFR2 Bi-Functional Antibody Planned to Enter the Clinic in 20 |
2024-10-28 |
| Kivu Bioscience. (10/28/24). "Kivu Bioscience Raises $92 Million Series A Led by Novo Holdings to Advance Next-Generation Antibody-Drug Conjugates". San Francisco, CA. |
2024-10-28 |
| ICR Inc.. (10/22/24). "Press Release: ICR Healthcare Launches as a Unified Global Brand in Healthcare Strategic Communications and Investor Relations". New York, NY & London. |
2024-10-22 |
| BenevolentAI Ltd.. (10/17/24). "Press Release: BenevolentAI Appoints Kenneth Mulvany as Executive Chairman". London. |
2024-10-17 |
| Nuclera Ltd.. (10/16/24). "Press Release: Nuclera Closes $75 Million USD Financing
> Series C round led by Elevage Medical Technologies". Cambridge & Boston, MA. |
2024-10-16 |
| Shift Bioscience Ltd.. (10/15/24). "Press Release: Shift Bioscience Raises $16M to Advance Cell Simulation AI Platform". Cambridge. |
2024-10-15 |
| Antiverse Ltd.. (10/15/24). "Press Release: Antiverse Raises £3.5M ($4.6M) to Advance Generative AI Antibody Design Platform". Cardiff. |
2024-10-15 |
| H. Lundbeck A/S. (10/14/24). "Press Release: Lundbeck to Acquire Longboard Pharmaceuticals in a Strategic Deal, Significantly Enhancing Its Neuroscience Pipeline". Valby & La Jolla, CA. |
2024-10-14 |
| Cosmo Pharmaceuticals N.V.. (10/11/24). "Press Release: Cosmo Pharmaceuticals Appoints New Chief Financial Officer". Dublin. |
2024-10-11 |
| Booster Therapeutics GmbH. (10/10/24). "Press Release: Booster Therapeutics Launches to Pioneer New Class of Proteasome Activator Medicines for the Treatment of a Range of Complex Diseases". Berlin. |
2024-10-10 |
| Purespring Therapeutics Ltd.. (10/9/24). "Press Release: Purespring Therapeutics Raises £80/$105 Million in a Series B Financing to Transform the Treatment of Kidney Diseases". London. |
2024-10-09 |
| Clock Bio Ltd.. (10/9/24). "Press Release: clock.bio Raises $5.3M Seed Funding and Decodes Genetic Atlas of Human Rejuvenation Factors". Cambridge. |
2024-10-09 |
| Calluna Pharma AS. (10/9/24). "Press Release: Calluna Pharma Appoints Mark Gaffney as Chief Executive Officer and Mark Altmeyer as Independent Chair of the Board". Oslo & Boston, MA. |
2024-10-09 |
| Ferring Pharmaceuticals S.A.. (10/3/24). "Press Release: Ferring Bolsters Global Gene Therapy Supply Chain with European Manufacturing Facility". Saint-Prex. |
2024-10-03 |
| Enara Bio Ltd.. (10/3/24). "Press Release: Enara Bio Raises $32.5 Million Series B Financing to Advance First-in-Class Pipeline of TCR-based Immunotherapies Targeting Novel Dark Antigens". Oxford. |
2024-10-03 |
| LoQus23 Therapeutics Ltd.. (10/2/24). "Press Release: LoQus23 Therapeutics Announces £35 Million (c.$43 Million) Series A Financing to Advance Its Small Molecule Somatic Expansion Inhibition Therapy for Huntington’s Disease". Cambridge. |
2024-10-02 |
| Evotec SE. (9/26/24). "Press Release: Evotec and Novo Nordisk Enter into Technology Development Partnership to Support Next-generation Cell Therapies". Hamburg. |
2024-09-26 |
| Constructive Biology Ltd.. (9/24/24). "Press Release: Constructive Bio Secures $58 Million in Series A Financing". Cambridge. |
2024-09-24 |
| Lift BioSciences Ltd.. (9/24/24). "Press Release: Lift BioSciences Raises £10m in First Close of Series A to Advance First-in-Class Allogeneic Innate Cell Therapy". Milan. |
2024-09-24 |
| Cosmo Pharmaceuticals N.V.. (9/23/24). "Press Release: Cosmo Pharmaceuticals Enhances Management Team with Newly Appointed Head of Global Business Development". Dublin. |
2024-09-23 |
| Organon & Co.. (9/18/24). "Press Release: Organon to Acquire Dermavant including Its Innovative Dermatologic Therapy, Vtama (tapinarof) Cream, 1%". Jersey City, NJ. |
2024-09-18 |
| NanoVation Therapeutics Inc.. (9/18/24). "Press Release: NanoVation Therapeutics Announces Multi-Target Partnership with Novo Nordisk to Develop Genetic Medicines Targeting Cardiometabolic and Rare Diseases". Vancouver, BC. |
2024-09-18 |
| Oribiotech Ltd.. (9/18/24). "Press Release: Ori Biotech and Charles River Laboratories Collaborate to Accelerate Life-Saving Cell and Gene Therapy Development and Manufacturing". Philadeliphia, PA. |
2024-09-18 |
| Forbion Capital Partners. (9/11/24). "Press Release: Forbion Leads $14m Series A in Solasta Bio to Advance Development and Commercialisation of First-in-class Sustainable Crop Protection Solutions". Naarden. |
2024-09-11 |
| Cellular Origins Ltd.. (9/11/24). "Press Release: Cellular Origins and 3P Innovation Collaborate to Accelerate Industrialisation of CGT Manufacturing". Cambridge. |
2024-09-11 |
| Closed Loop Medicine Ltd.. (9/11/24). "Press Release: Closed Loop Medicine Appoints Luba Greenwood as Chair of the Board of Directors". London. |
2024-09-11 |
| PhoreMost Ltd.. (9/10/24). "Press Release: PhoreMost Extends Series B Financing to $50M to Advance High-value Oncology and Inflammation Degrader Programmes". Cambridge. |
2024-09-10 |
| Miltenyi Biotec B.V. & Co. KG. (9/10/24). "Press Release: Miltenyi Biotec Manufactures Lentiviral Vector for Adaptimmune’s FDA-approved TCR T-cell therapy Tecelra (afamitresgeme autoleucel)". Bergisch Gladbach. |
2024-09-10 |
| Agronomics Ltd.. (9/10/24). "Press Release: Formo Closes a US$ 61 Million Series B Round". |
2024-09-10 |
| Oxford Nanopore Technologies plc. (9/10/24). "Press Release: Oxford Nanopore Seeks Discovery in Connection with Anticipated Breach of Contract Action". |
2024-09-10 |
| NanoSyrinx Ltd.. (9/10/24). "Press Release: NanoSyrinx Closes £10 Million GBP Financing and Appoints Dr. Edwin Moses as Chairman". Coventry. |
2024-09-10 |
| Ion Opticks Pty Ltd.. (9/10/24). "Press Release: IonOpticks Partners with Adelis to Accelerate Global Expansion and Innovation". Melbourne & Stockholm. |
2024-09-10 |
| Epsilogen Ltd.. (9/9/24). "Press Release: Epsilogen Completes £12.5 Million Series B Financing Expansion". London. |
2024-09-09 |
| Genedata AG. (9/5/24). "Press Release: Immunocore Selects Genedata to Scale Up Discovery of Novel TCR Therapeutics". Basel. |
2024-09-05 |
| ERS Genomics Ltd.. (9/4/24). "Press Release: ERS Genomics and Medicines Discovery Catapult Sign CRISPR/Cas9 License Agreement". Dublin & Cheshire. |
2024-09-04 |
| Molport Inc.. (9/3/24). "Press Release: Molport Welcomes Diana Zelencova-Gopejenko as CEO". Riga. |
2024-09-03 |
| Exscientia plc. (8/28/24). "Press Release: Exscientia to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference". Oxford. |
2024-08-28 |
| Qiagen N.V.. (8/28/24). "Press Release: Qiagen Expands QIAstat-Dx into Precision Medicine through Partnership for Companion Diagnostics in Chronic Diseases". Venlo. |
2024-08-28 |
| BoobyBiome Ltd.. (8/22/24). "Press Release: BoobyBiome Secures £1.6M Innovate UK Biomedical Catalyst Grant for Groundbreaking Synbiotic Research". London. |
2024-08-22 |
| BioArctic AB. (8/22/24). "Press Release: Leqembi (lecanemab) Authorized for Early Alzheimer’s Disease in Great Britain". Stockholm. |
2024-08-22 |
| Coulter Partners. (8/22/24). "Press Release: Coulter Partners Places Industry Veteran Dr. David Hung as Chair of T-Therapeutics". |
2024-08-22 |
| BRAIN Biotech AG. (8/22/24). "Press Release: BRAIN Biotech AG Launches the Innovative Technology Platform MetXtra Enabling Unique Enzyme Solutions". Zwingenberg. |
2024-08-22 |
| Supreme Optimization. (8/21/24). "Press Release: Supreme Group Acquires BioStrata, an Award-Winning UK-Based Life Science Marketing and Public Relations Agency". West Chester, PA & Cambridge. |
2024-08-21 |
| Adcendo ApS. (8/20/24). "Press Release: Adcendo ApS and Multitude Therapeutics Inc. Announce Global Development and Commercialization Agreement on First-in-class ADC Drug Candidate Targeting Tissue Factor". Copenhagen & Shanghai. |
2024-08-20 |
| Fujifilm Diosynth Biotechnologies UK Ltd.. (8/20/24). "Press Release: Fujifilm Diosynth Biotechnologies Celebrates Opening of Billingham, UK Microbial Manufacturing Facility". Billingham. |
2024-08-20 |
| MeiraGTx Holdings plc. (8/12/24). "Press Release: MeiraGTx Announces Pricing of Offering of Ordinary Shares Led by Sanofi". London & New York, NY. |
2024-08-12 |
| Balderton Capital. (8/12/24). "Press Release: Balderton Announces $1.3B in New Funds to Back Europe’s Top Entrepreneurs as They Build World-changing Businesses". |
2024-08-12 |
| Recursion Pharmaceuticals, Inc.. (8/8/24). "Press Release: Recursion and Exscientia Enter Definitive Agreement to Create a Global Technology-Enabled Drug Discovery Leader with End-to-End Capabilities". Salt Lake City, UT & Oxford. |
2024-08-08 |
| Bavarian Nordic A/S. (8/8/24). "Press Release: Bavarian Nordic Receives USD 156.8 Million from the U.S. Government for Additional Smallpox/Mpox Vaccine Production". Copenhagen. |
2024-08-08 |
| Carbios S.A.. (8/6/24). "Press Release: Carbios and FCC Environment Announce Joint Project to Establish UK-based PET Biorecycling Facility Using Carbios’ Licensed Technology". Clermont-Ferrand & Doncaster. |
2024-08-06 |
| Biomatter Designs. (8/5/24). "Press Release: Biomatter Raises a €6.5 Million Seed Round to Unlock the Power of Generative AI for Enzyme Design". Vilnius. |
2024-08-05 |
| Adaptimmune Therapeutics plc. (8/1/24). "Press Release: Adaptimmune Receives U.S. FDA Accelerated Approval of TECELRA® (afamitresgene autoleucel), the First Approved Engineered Cell Therapy for a Solid Tumor". Philadeliphia, PA & Oxford. |
2024-08-01 |
| iotaSciences Ltd.. (7/31/24). "Press Release: iotaSciences Raises Equity Financing Round to Drive further Business Expansion for Its Automated Single-cell Biology Handling Technologies". Oxford. |
2024-07-31 |
| Montara Therapeutics, Inc.. (7/30/24). "Press Release: Montara Therapeutics Closes $8 Million Seed Round Led by SV Health Investors’ Dementia Discovery Fund and Two Bear Capital". San Francisco, CA. |
2024-07-30 |
| Flo Health UK Ltd.. (7/30/24). "Press Release: Flo Health Secures More than $200M Investment from General Atlantic to Revolutionize Women’s Health; First Purely Digital Consumer Women’s Health App to Achieve Unicorn Status". London. |
2024-07-30 |
| Kadans Science Partner. (7/24/24). "Press Release: Kadans Science Partner Commences Work on New Purpose-built Wet Lab Facilities at Merlin Place, North Cambridge". Cambridge. |
2024-07-24 |
| Broken String Biosciences Ltd.. (7/24/24). "Press Release: Broken String Biosciences Appoints Steve Becker as Chief Commercial Officer". Cambridge. |
2024-07-24 |
| Pinetree Therapeutics, Inc.. (7/23/24). "Press Release: Pinetree Therapeutics Announces Exclusive Option and Global License Agreement for Preclinical EGFR Degrader Candidate with AstraZeneca". Cambridge, MA. |
2024-07-23 |
| Valneva S.E.. (7/22/24). "Press Release: CEPI Expands Partnership with Valneva with a $41.3 Million Grant to Support Broader Access to the World’s First Chikungunya Vaccine". Oslo & Saint-Herblain. |
2024-07-22 |
| Neurocare Group AG. (7/22/24). "Press Release: Neurocare Group Announces Acquisition of Smart TMS Clinics in the UK". Munich & London. |
2024-07-22 |
| Draupnir Bio ApS. (7/1//24). "Press Release: Draupnir Bio Completes €12 Million Seed Round to Progress Development of Oral Small Molecule Degraders of Extracellular Proteins". Copenhagen. |
2024-07-17 |
| Oxford Biomedica plc. (7/17/24). "Press Release: Oxford Biomedica Announces Chief Financial Officer Transition. Lucinda Crabtree to Join as Chief Financial Officer". Basel. |
2024-07-17 |
| Huma Therapeutics Ltd.. (7/16/24). "Press Release: Huma Completes Series D with Total Financing of over $80m as It Launches Huma Cloud Platform with GenAI Integrations to Bring Digital First Care and Research to Everyone". London & New York, NY. |
2024-07-16 |
| Asceneuron S.A.. (7/16/24). "Press Release: Asceneuron Secures $100 Million Series C Financing to Advance Groundbreaking Therapeutics in Neurodegenerative Diseases". Lausanne & San Francisco, CA. |
2024-07-16 |
![[LSE] Life-Sciences-Europe.com - The European Life Sciences Web Portal](/images/basics/lse-life-sciences-europe-portal-logo.svg){kind=logo}
Date
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
